Lean-mass hyper-responders

Some lean, fit, metabolically healthy people who go on a ketogenic diet end up with very high LDL cholesterol alongside high HDL and low triglycerides. The data offered as reassurance are thin: one snapshot scan of plaque, and the follow-up paper claiming their apoB didn't predict plaque growth was retracted in 2026.

If this is you, treat the high LDL as an unresolved risk, not a safe exception. If you want to stay in ketosis without gambling on unproven long-term risk, a cholesterol-absorption drug (ezetimibe) can lower your particle count; discuss it with a clinician.

Who they are

A ketogenic diet is a very-low-carbohydrate diet that makes the body run mainly on fat. In a specific group of lean, fit, metabolically healthy people it produces a striking triad: very high LDL cholesterol (LDL-C), often above 4.9 mmol/L (190 mg/dL) and sometimes far higher, high HDL cholesterol, and low triglycerides. These are the "lean-mass hyper-responders."

The proposed mechanism, called the Lipid Energy Model, is that with carbohydrate scarce, a lean liver ships large amounts of fat to muscle for fuel in triglyceride-rich particles, which then remodel into many LDL particles; the leaner the person, the higher the LDL spike. It is a proposal, not an established finding.

The reassuring scan, and what it can't show

In a single snapshot scan, 80 hyper-responders (average age about 55, on keto for about 4.7 years, average LDL-C about 7.0 mmol/L or 272 mg/dL) had no more coronary plaque than 80 matched people with LDL-C around 3.2 mmol/L (123 mg/dL).^[1]

That is less reassuring than it sounds. Both groups had very little plaque, and a single scan cannot show whether plaque is growing.

The follow-up was retracted

A one-year follow-up from the same study claimed that plaque growth was predicted by existing plaque and not by apoB, the protein that marks each plaque-building particle. It was retracted in 2026 at the request of the authors and the editors because of errors in its methods.^[2] Claims that "plaque predicts plaque, apoB does not" in this group rest on that withdrawn paper.

What keto does to LDL in trials

Across randomised trials in adults aged 35–75 with at least one cardiovascular risk factor, ketogenic diets raised LDL-C by about 0.4 mmol/L (17 mg/dL) on average compared with low-fat, moderate-carbohydrate diets.^[3] Hyper-responders' rises are many times larger than that average.

What is missing

There are no data on heart attacks, strokes or deaths for this group, and a few years of follow-up is short for a disease that takes decades to develop. Plaque builds from the number of particles in the blood multiplied by the years of exposure; see Cholesterol for why that lifetime exposure is what matters. The honest position is uncertainty, not reassurance.

What to do

Don't read a clean or near-clean scan as clearance. One snapshot can't show whether plaque is growing.
Don't rely on the "plaque predicts plaque, apoB does not" claim. The paper behind it was retracted.
If you want to stay in ketosis, ask a clinician about ezetimibe, which lowers apoB by blocking cholesterol absorption.